These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20596663)

  • 21. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
    Zhao L; Liu Y; Sun X; Peng K; Ding Y
    J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
    Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
    Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
    Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
    Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
    Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
    Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
    Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
    Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
    PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
    Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
    Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.
    Liu W; Ma Y; Huang L; Peng J; Zhang P; Zhang H; Chen J; Qin H
    Mol Biol Rep; 2010 Oct; 37(7):3207-16. PubMed ID: 19842058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differential expression of secretagogin and glucose-related protein 78 in colorectal carcinoma: a proteome study].
    Xing XM; Wang YH; Huang Q; Lü BJ; Lai MD
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):107-12. PubMed ID: 17493385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis reveals novel proteins associated with progression and differentiation of colorectal carcinoma.
    Gan Y; Chen D; Li X
    J Cancer Res Ther; 2014; 10(1):89-96. PubMed ID: 24762493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of MEK1 and DIAPH3 expression in colorectal adenoma-carcinoma sequence.
    Foda AAM; El-Hawary AK; Elnaghi K; Eldehna WM; Enan ET
    Tumour Biol; 2024; 46(1):1-11. PubMed ID: 38728194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
    Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
    Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
    Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiling of differentially expressed proteins in stage IV colorectal cancers with good and poor outcomes.
    Kim HJ; Kang UB; Lee H; Jung JH; Lee ST; Yu MH; Kim H; Lee C
    J Proteomics; 2012 Jun; 75(10):2983-97. PubMed ID: 22178445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.